Resmed Inc (RMD) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Resmed Inc   (NYSE: RMD)


Resmed Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Resmed Inc's ROI in the first quarter of 2026?
Resmed Inc achieved a return on average invested assets (ROI) of 21.93 % in its first quarter of 2026, this is above RMD's average return on investment of 15.04%.
Resmed Inc s investments during the 12 months ending in the first quarter of 2026 are valued at $7 billion

ROI has improved compared to 20.79% in the fourth quarter of 2026, due to net income growth.

Within the Healthcare sector 52 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 311, from total ROI ranking in the fourth quarter of 2026 at 323.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Investment Change TTM 7.15 % 11.08 % 14.69 % 14.13 % 10.88 %
Y / Y Net Income Change TTM 10.8 % 8.75 % 48.83 % 126.51 % 361.82 %
Investment (TTM) in Millions 6,805 7,571 7,433 7,255 7,053
Return On Investment (TTM) 21.93 % 20.79 % 21.03 % 21.16 % 21.21 %
RMD's Overall Ranking # 311 # 323 # 269 # 308 #
Seq. Investment Change TTM -0.84 % 1.44 % 2.87 % 3.56 % 2.78 %
Seq. Net Income Change TTM 4.59 % 0.25 % 2.27 % 3.34 % 2.65 %
Net Income (TTM) in Millions 1,593 1,523 1,520 1,486 1,438

RMD Company Profile >> Back to RMD Roi Comparisons >> See Annual RMD Return On Investment



Return On Investment RMD's Ranking
Within: No.
Industry # 11
Sector # 53
Overall # 311

Return On Investment Statistics
High Average Low
20.57 %
15.04 %
7.18 %
(Jun 30 2025)   (Jun 30 2013)







Financial Statements
Resmed Inc's I. Quarter Investments $ 6,805 Millions RMD's Balance sheet
Resmed Inc's I. Quarter Income $ 418 Millions Quarterly RMD's Income Statement
RMD's Income by Division See RMD's Income by Division


RMD Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 7,571 7,155 5,962 5,993 4,407
Y / Y Investment Growth 5.81 % 20.02 % -0.52 % 36.01 % 15.46 %
Net Income in Millions 1,523 1,401 1,021 898 779
Y / Y Net Income Growth 8.75 % 37.2 % 13.75 % 15.15 % 64.26 %
Annual Return On Investment 20.12 % 19.58 % 17.13 % 14.98 % 17.69 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 20.12 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RMD's Competitors
Subscribers only: Roi for Resmed Inc's Suppliers
Subscribers only: Return On Investment for RMD's Customers

Other Ratios
RMD's Roa RMD's Inventory Turnover Ratio RMD's Growth Rates RMD's Dividend Statistics
RMD's Profitability Ratios RMD's Asset Turnover Ratio RMD's Dividend Growth
RMD's Roe RMD's Valuation Ratios RMD's Financial Strength Ratios RMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %

Date modified: 2026-10-31T10:01:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.